Correction: Continuous versus intermittent infusion of β-lactams in patients with sepsis and septic shock: a systematic review and meta-analysis (BMC Infectious Diseases, (2025), 25, 1, (1138), 10.1186/s12879-025-11504-2)

Tejada D.A.; García H.C.; Tomás-Alvarado E.; Yangali-Vicente J.; Rivera-Lozada O.; Barboza J.J. · BMC Infectious Diseases (2026) · DOI: 10.1186/s12879-025-12213-6

Resumen

Correction to: BMC Infect Dis. 2025;251138. https://doi.org/10.1186/s12879-025-11504-2. Following publication of the original article [1], we were notified that from Figure 3, 4, 5 and 6, there was a mismatch between the figure captions and the actual displayed content. Originally published caption: Effect on primary outcomes: (a) APACHE II; (b) All-cause mortality. Corrected caption: All-cause mortality; Hospital mortality; All-cause ICU mortality. Originally published caption: Effect on secondary outcomes: (a) Length of ICU stay; (b) Length of hospital stay; (c) ICU survivors; (d) Hospital survivors. Corrected caption: ICU survivors; Hospital survivors; Survival at study completion. Originally published caption: Effect on secondary outcomes: (a) Clinical cure; (b) Adverse events. Corrected caption: (a) Clinical cure; (b) Clinical outcomes before 2015 / 2016–2020 / after 2020. Originally published caption: Effect on secondary outcomes: (a) Survival at study completion. Corrected caption: Identical to the figure presented under Figure 5 (i.e., Clinical cure and stratified clinical outcomes), suggesting an inadvertent duplication. The original article has been corrected. © The Author(s) 2025.

Instituciones: Universidad Señor de Sipán